Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 734 of 1,261

  1. US 9133129

    Bicyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  2. US 9133127

    Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

    Jenrin Discovery, LLC · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  3. US 9132210

    Scaffolds for cell transplantation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  4. US 9132201

    Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers

    UNIVERSITY OF TWENTE, INSTITUTE FOR BIOMEDICAL AND TECHNICAL MEDICINE (MIRA) · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  5. US 9132200

    Oligomer-calcium channel blocker conjugates

    Nektar Therapeutics · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  6. US 9132174

    Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

    Anchored RSK3 Inhibitors, LLC · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  7. US 9132152

    Compositions and methods for generating induced pluripotent stem cells

    The Regents of the University of California · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  8. US 9132122

    1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones

    Addex Pharma, S.A. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  9. US 9132135

    Method of treating organophosphorous poisoning

    The United States of America as represented by the Secretary of the Army · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  10. US 9133259

    Cartilage oligomeric matrix protein (COMP)—growth factor complexes and uses thereof

    The Regents of the University of California · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  11. US 9133133

    2,4-pyridinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  12. US 9132192

    Anti-EGFR antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  13. US 9132087

    Auris formulations for treating otic diseases and conditions

    The Regents of the University of California · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  14. US 9132096

    Abuse resistant pharmaceutical compositions

    REKHI GURVINDER SINGH [US] · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  15. US 9132138

    Method for the treatment of multiple sclerosis

    CASI Pharmaceuticals, Inc · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  16. US 9133200

    Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors

    Almirall, S.A. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  17. US 9126926

    Oligomer-anticholinergic agent conjugates

    Nektar Therapeutics · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  18. US 9127277

    Methods and compositions for prevention or treatment of RSV infection

    Alnylam Pharmaceuticals, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  19. US 9127053

    Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  20. US 9127045

    Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides

    The Regents of the University of California · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  21. US 9125833

    Multimodal abuse resistant and extended release opioid formulations

    Relmada Therapeutics, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  22. US 9128080

    Modified T cell receptors and related materials and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  23. US 9128093

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  24. US 9127274

    Serpinc1 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.